Connect with us
Financial Press
the-wall-street-journal:-how-the-kodak-generic-drug-ingredients-deal-developed,-and-why-it-fell-apart:-a-snapshot
the-wall-street-journal:-how-the-kodak-generic-drug-ingredients-deal-developed,-and-why-it-fell-apart:-a-snapshot

Breaking

The Wall Street Journal: How the Kodak generic-drug ingredients deal developed, and why it fell apart: a snapshot

The Wall Street Journal

Trump trade adviser Peter Navarro called the Kodak project a ‘great win for the American people’ in late July, but two weeks later he was characterizing executives at the legendary photography company as having undertaken ‘probably the dumbest decisions made by executives in corporate history’

Peter Navarro speaks to members of the press outside the West Wing on June 18.


Getty Images

On a white board in his office earlier this year, Trump trade adviser Peter Navarro made a list of potential companies that could manufacture pharmaceuticals in the U.S.

He separated them into three columns, one for each stage of the production process. Eastman Kodak Co. stood out, overlapping two of the three columns. The way Navarro saw it, he recalled, Kodak could help produce the ingredients to jump-start generic drug production and ease the country’s reliance on foreign supplies.

Written By

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles

Breaking

Published: Sept. 24, 2020 at 10:13 a.m. ET Two young women, one of whom is wearing a face mask, walk in Frankfurt am Main,...

Breaking

The Moneyist Published: Sept. 25, 2020 at 4:18 a.m. ET ‘If she agrees to move, and puts the money in her bank account —...

Breaking

Another tragic wildfire season will lead thousands of people across the West Coast — particularly in California — to move to greener pastures, by...

Breaking

That’s weighty rhetoric, but it’s also intangible. How might the candidates affect the things you can see and hold, like a paystub, an income...